A recent study using iPSC-derived neurons and knockout mouse models accurately replicated key features of DTDS, such as impaired DAT activity, elevated dopamine metabolites, and neurodegeneration. The gene discussed is SLC6A3; the disease is SLC6A3-related dopamine transporter deficiency syndrome.